| Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis CJL Murray, KS Ikuta, F Sharara, L Swetschinski, GR Aguilar, A Gray, ... The lancet 399 (10325), 629-655, 2022 | 7537 | 2022 |
| Prevalence of underlying diseases in hospitalized patients with COVID-19: a systematic review and meta-analysis A Emami, F Javanmardi, N Pirbonyeh, A Akbari Archives of academic emergency medicine 8 (1), 2020 | 1132 | 2020 |
| Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019 KS Ikuta, LR Swetschinski, GR Aguilar, F Sharara, T Mestrovic, AP Gray, ... The Lancet 400 (10369), 2221-2248, 2022 | 653 | 2022 |
| Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global … KR Paulson, AM Kamath, T Alam, K Bienhoff, GG Abady, J Abbas, ... The Lancet 398 (10303), 870-905, 2021 | 322 | 2021 |
| Long COVID syndrome‐associated brain fog AA Asadi‐Pooya, A Akbari, A Emami, M Lotfi, M Rostamihosseinkhani, ... Journal of medical virology 94 (3), 979-984, 2022 | 198 | 2022 |
| SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study H Poustchi, M Darvishian, Z Mohammadi, A Shayanrad, A Delavari, ... The Lancet Infectious Diseases 21 (4), 473-481, 2021 | 178 | 2021 |
| Health system performance in Iran: a systematic analysis for the Global Burden of Disease Study 2019 F Farzadfar, M Naghavi, SG Sepanlou, SS Moghaddam, WJ Dangel, ... The Lancet 399 (10335), 1625-1645, 2022 | 167 | 2022 |
| Long COVID in children and adolescents AA Asadi-Pooya, H Nemati, M Shahisavandi, A Akbari, A Emami, M Lotfi, ... World Journal of Pediatrics 17, 495-499, 2021 | 157 | 2021 |
| Prevalence of underlying diseases in died cases of COVID-19: A systematic review and meta-analysis F Javanmardi, A Keshavarzi, A Akbari, A Emami, N Pirbonyeh PloS one 15 (10), e0241265, 2020 | 129 | 2020 |
| Risk factors associated with long COVID syndrome: a retrospective study AA Asadi-Pooya, A Akbari, A Emami, M Lotfi, M Rostamihosseinkhani, ... Iranian journal of medical sciences 46 (6), 428, 2021 | 124 | 2021 |
| Age–sex differences in the global burden of lower respiratory infections and risk factors, 1990–2019: results from the Global Burden of Disease Study 2019 HH Kyu, A Vongpradith, SB Sirota, A Novotney, CE Troeger, MC Doxey, ... The Lancet infectious diseases 22 (11), 1626-1647, 2022 | 110 | 2022 |
| Global, regional, and national sex differences in the global burden of tuberculosis by HIV status, 1990–2019: results from the Global Burden of Disease Study 2019 JR Ledesma, J Ma, A Vongpradith, ER Maddison, A Novotney, MH Biehl, ... The lancet infectious diseases 22 (2), 222-241, 2022 | 94 | 2022 |
| Seizure in patients with COVID-19 A Emami, N Fadakar, A Akbari, M Lotfi, M Farazdaghi, F Javanmardi, ... Neurological Sciences 41, 3057-3061, 2020 | 71 | 2020 |
| Influenza viral infections among the Iranian Hajj pilgrims returning to Shiraz, Fars province, Iran A Moattari, A Emami, M Moghadami, B Honarvar Influenza and other respiratory viruses 6 (6), e77-e79, 2012 | 57 | 2012 |
| The frequency of exotoxin A and exoenzymes S and U genes among clinical isolates of Pseudomonas aeruginosa in Shiraz, Iran A Yousefi-Avarvand, R Khashei, HS Ebrahim-Saraie, A Emami, ... International journal of molecular and cellular medicine 4 (3), 167, 2015 | 53 | 2015 |
| Seroprevalence of anti-rubella and anti-measles IgG antibodies in pregnant women in Shiraz, Southern Iran: outcomes of a nationwide measles-rubella mass vaccination campaign B Honarvar, M Moghadami, A Moattari, A Emami, N Odoomi, ... PLoS One 8 (1), e55043, 2013 | 47 | 2013 |
| Hidden threat lurking behind the alcohol sanitizers in COVID‐19 outbreak A Emami, F Javanmardi, A Keshavarzi, N Pirbonyeh Dermatologic therapy 33 (4), e13627, 2020 | 45 | 2020 |
| COVID‐19 presentations and outcome in patients with epilepsy AA Asadi‐Pooya, A Emami, A Akbari, F Javanmardi Acta Neurologica Scandinavica 143 (6), 624-628, 2021 | 44 | 2021 |
| Survival rate in hypertensive patients with COVID-19 A Emami, F Javanmardi, A Akbari, J Kojuri, H Bakhtiari, T Rezaei, ... Clinical and experimental hypertension 43 (1), 77-80, 2021 | 37 | 2021 |
| COVID-19 in patients with Down syndrome A Emami, F Javanmardi, A Akbari, AA Asadi-Pooya Neurological Sciences 42, 1649-1652, 2021 | 34 | 2021 |
Neda PirbonyehBacteriology & Virology department, Medical School, Shiraz University of Medical Sciences, Shiraz在 sums.ac.ir 的电子邮件经过验证
